NAFLD-derived plasminogen activator inhibitor 1, vascular endothelial growth factor (VEGF) or angiopoietin may be involved in metastasis and thus cancer progression [54]. This evidence concerns the gene SERPINE1 and metabolic dysfunction-associated steatotic liver disease.